Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices and the only known provider of a non-magnetic intravenous ("IV") infusion...

IRMD : 25.76 (+7.74%)
Iradimed Corp Up 3.2% Since SmarTrend Uptrend Call (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 4 months, Iradimed Corp has returned 3.18% as of today's recent price of $23.49.

IRMD : 25.76 (+7.74%)
IRadimed (IRMD) Q3 Earnings and Revenues Beat Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 53.33% and 1.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results

-- Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30. IRADIMED management will host...

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System

IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter.

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer,...

MS : 50.69 (+2.51%)
IRMD : 25.76 (+7.74%)
IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 33.33% and 3.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results

-- Reports second quarter 2019 revenue of $9.2 million

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step...

IRMD : 25.76 (+7.74%)
Shares of IRMD Down 26.8% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.31. In approximately 3 months, Iradimed Corp has returned 26.85% as of today's recent price of $19.25.

IRMD : 25.76 (+7.74%)
Iradimed Corp Shares Down 30.0% Since SmarTrend's Sell Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.32. In approximately 3 months, Iradimed Corp has returned 29.96% as of today's recent price of $18.43.

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, July 30. iRadimed management will host a...

IRMD : 25.76 (+7.74%)
Shares of IRMD Down 25.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.31. In approximately 2 months, Iradimed Corp has returned 25.59% as of today's recent price of $19.58.

IRMD : 25.76 (+7.74%)
Iradimed Corp Down 24.9% Since SmarTrend Downtrend Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.31. In approximately 2 months, Iradimed Corp has returned 24.95% as of today's recent price of $19.75.

IRMD : 25.76 (+7.74%)
Iradimed Corp Down 10.9% Since SmarTrend Downtrend Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.32. In approximately 2 weeks, Iradimed Corp has returned 10.91% as of today's recent price of $23.44.

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results

-- Reports first quarter 2019 revenue of $8.4 million

IRMD : 25.76 (+7.74%)
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30. IRADIMED management will host a...

IRMD : 25.76 (+7.74%)
Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion Financial, iRadimed, and Stewart Information Services -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Noble Energy Inc. (NYSE:NBL),...

IRMTF : 11.9650 (unch)
NBL : 22.94 (+4.13%)
AVD : 17.22 (+1.53%)
CLXT : 7.09 (+17.19%)
MFIN : 7.10 (+2.01%)
IRMD : 25.76 (+7.74%)
STC : 41.65 (-0.53%)
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor

IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry ("SpO2") and Capnography ("CO2") monitoring features of its 3880 Magnetic...

IRMD : 25.76 (+7.74%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.41 , AIZ +0.17 , SBAC -7.72 , SO +0.02 , WELL -2.04
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar